<a href='https://brc.riken.jp/mus/pcr09762'>Genotyping protocol -PCR-</a> Frmpd1はFREMドメインとPDZドメインを持つ足場蛋白質 RBRC09762 条件を付加する。<br>利用者は、事前に寄託者の提供承諾(大阪大学とのMTA締結)を得る。学術機関の学術研究に限る。利用者は提供者との共同研究を行うことを条件とする。 Developed by Takahisa Furukawa, Institute for Protein Research, Osaka University. B6C3HF1-derived fertilized eggs were used. Mixed genetic background. Frmpd1(FERM and PDZ domain containing 1)mutant mice generated by the CRISPR/Cas9. A part of exon 3 was deleted.Deleted sequence: CCCAGGCACTCACG at exon 3 Necessary documents for ordering:<ol><li>Order form (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_4.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_b.docx">English</A>)</li><li>Category I MTA: CRISPR/Cas9 genome edited bioresources (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/Broad_MTA_J.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/Broad_MTA_E.docx">English</A>)</li><li>Acceptance of responsibility for living modified organism (<A HREF="https://mus.brc.riken.jp/ja/wp-content/uploads/form/form_7.docx">Japanese</A> / <A HREF="https://mus.brc.riken.jp/en/wp-content/uploads/form/form_g.docx">English</A>)</li></ol> Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must contract an MTA with the DEPOSITOR (Osaka University). The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. The RECIPIENT must perform the study on a collaboration basis with the DEPOSITOR. Frmpd1 KO2マウス Frmpd1 KO2 mice pX330-U6-Chimeric_BB-CBh-hSpCas9[human U6 promoter, S. pyogenes gRNA scaffold, human U6 terminator, CMV,chicken hybrid CMV enhancer/chicken beta-actin promotor (CBh), Synthetic DNA 3xFLAG, SV40 nuclear localization signal(NLS), Streptococcus pyogenes SpCas9 (human codon-optimized), bovine GH polyA signal, AAV2 inverted terminal repeat (ITR), f1 phage f1 origin, E. coli Ampicillin resistance gene (AmpR), E. coli pUC origin] true C(3〜6か月) C (3-6 months) 大阪大学 蛋白質研究所、分子発生学研究室において確立(2016年)。CRISPR/CAS9法によりデリーションを生じた個体を維持。交配歴としては、B6Jと2度掛け合わせ、その後は兄妹交配により維持していた。+/- は雌雄ともに交配可能である。 B6;B6C3-Frmpd1<em1Tfur> B6;B6C3-Frmpd1<em1Tfur>